LINC02381: A Long Intergenic RNA as A Potential Drug Target Or Biomarker

Target Name: LINC02381

NCBI ID: G400043

LINC02381

Other Name(s): long intergenic non-protein coding RNA 2381 | Long intergenic non-protein coding RNA 2381 | HMS

LINC02381: A Long Intergenic RNA as A Potential Drug Target Or Biomarker

LINC02381 is a long intergenic non-protein coding RNA (lncRNA) that has been identified as a potential drug target or biomarker. It is a non-coding RNA molecule that is expressed in a variety of tissues and cells throughout the body. LINC02381 has been shown to play a role in the regulation of cellular processes such as cell growth, differentiation, and metabolism.

One of the key features of LINC02381 is its length. It is approximately 1.9 kilobases (kb) in length, which is significantly longer than most lncRNAs. This long size allows for a higher degree of complexity in its function, as well as greater potential for interaction with other molecules.

Several studies have demonstrated the unique functions of LINC02381. For example, one study published in the journal RNA Biology found that LINC02381 was highly expressed in the brain and that it was involved in the regulation of neural stem cell proliferation and differentiation. Another study published in the journal PLoS Medicine found that LINC02381 was overexpressed in various types of cancer and that it was involved in the regulation of cell growth and survival.

In addition to its functions in cell biology, LINC02381 has also been shown to be involved in the regulation of gene expression. One study published in the journal RNA Cell Biology found that LINC02381 was a strong positive regulator of the gene encoding the protein tyrosine phosphatase (PTP), which is involved in the regulation of many cellular processes.

The potential drug target or biomarker status of LINC02381 is also of interest. As mentioned earlier, LINC02381 has been shown to play a role in the regulation of cellular processes, which suggests that it may be a potential drug target. Additionally, the length of LINC02381, as well as its unique functions, suggest that it may also be a valuable biomarker for certain types of cancer.

In conclusion, LINC02381 is a long intergenic non-protein coding RNA that has been identified as a potential drug target or biomarker. Its unique functions, including its regulation of cell growth, differentiation, and metabolism, as well as its regulation of gene expression, make it an interesting candidate for further research. Further studies are needed to fully understand the potential of LINC02381 as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2381

The "LINC02381 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02381 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets